What Lexicon Pharmaceuticals, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 8 |
| Sells | 0 | 0 |
| Total trades | 0 | 45 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 47,298,970 |
| Disposed | 0 | 676,672 |
| Net activity | +0 | +46,622,298 |
Common stock only — 2 reported trades in the last 12 months are in a security these totals do not cover.
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Debbane Raymond | Director | Jun 03 | Exercise / conversion · M | +89,312 | — | — | 1,995,498 |
| Amouyal Philippe | Director | Jun 03 | Exercise / conversion · M | +89,312 | — | — | 374,486 |
| Barker Sam L | Director | Jun 03 | Exercise / conversion · M | +89,312 | — | — | 213,771 |
| Sobecki Christopher J | Director | Jun 03 | Exercise / conversion · M | +89,312 | — | — | 293,177 |
| Cheung Ivan | Director | Jun 03 | Exercise / conversion · M | +89,312 | — | — | 89,312 |
| Sullivan Diane E. | Director | Jun 03 | Exercise / conversion · M | +89,312 | — | — | 126,122 |
| Swain Judith L | Director | Jun 03 | Exercise / conversion · M | +89,312 | — | — | 174,486 |
| Artal Participations S.a r.l. | Director | Apr 30 | Exercise / conversion · M | +20,421,735 | — | — | 175,156,062 |
| Gopinathan Suma | SVP, Discovery | Feb 28 | Withheld — tax / exercise cost · F | −24,338 | $1.47 | −$35.8K | 150,132 |
| Gopinathan Suma | SVP, Discovery | Feb 28 | Exercise / conversion · M | +65,640 | — | — | 174,470 |
| Gopinathan Suma | SVP, Discovery | Feb 28 | Exercise / conversion · M | +20,310 | — | — | 108,830 |
| Gopinathan Suma | SVP, Discovery | Feb 28 | Exercise / conversion · M | +14,000 | — | — | 88,520 |
| DeFrancesco Lisa | SVP, IR and Corp Comm | Feb 28 | Withheld — tax / exercise cost · F | −74,572 | $1.47 | −$110K | 93,869 |
| DeFrancesco Lisa | SVP, IR and Corp Comm | Feb 28 | Exercise / conversion · M | +128,190 | — | — | 168,441 |
| DeFrancesco Lisa | SVP, IR and Corp Comm | Feb 28 | Exercise / conversion · M | +24,674 | — | — | 40,251 |
| Granowitz Craig B | SVP, Chief Medical Officer | Feb 28 | Withheld — tax / exercise cost · F | −109,098 | $1.47 | −$160K | 323,430 |
| Granowitz Craig B | SVP, Chief Medical Officer | Feb 28 | Exercise / conversion · M | +202,260 | — | — | 432,528 |
| Granowitz Craig B | SVP, Chief Medical Officer | Feb 28 | Exercise / conversion · M | +74,226 | — | — | 230,268 |
| Granowitz Craig B | SVP, Chief Medical Officer | Feb 28 | Exercise / conversion · M | +35,790 | — | — | 156,042 |
| Coiante Scott M | SVP, Chief Financial Officer | Feb 28 | Withheld — tax / exercise cost · F | −54,881 | $1.47 | −$80.7K | 105,356 |
Loading...